ClinicalThought
View More
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
Expert commentary on key studies on safety and efficacy of JAK inhibitors from EULAR 2020 as reported by CCO
Eric M. Ruderman, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: July 16, 2020
Expired: July 15, 2021
Expert commentary on key studies in RA prevention and treatment from EULAR 2020 as reported by CCO
Paul Emery, MA, MD, FRCP
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: July 16, 2020
Expired: July 15, 2021
From EULAR 2020, 52-week analysis of FINCH 1 trial of add-on filgotinib in rheumatoid arthritis with inadequate methotrexate response, by CCO
From EULAR 2020, new safety analysis of upadacitinib use in patients with RA from 5 phase III SELECT trials
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.